Synergistic interaction of adrenaline and histamine in human platelet aggregation is mediated through activation of phospholipase, map kinase and cyclo-oxygenase pathways
- 1 November 2000
- journal article
- Published by Elsevier in Pharmacological Research
- Vol. 42 (5) , 479-483
- https://doi.org/10.1006/phrs.2000.0721
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Co-activation of Gi and Gq proteins exerts synergistic effect on human platelet aggregation through activation of phospholipase C and Ca2+ signalling pathwaysExperimental & Molecular Medicine, 1999
- The inhibitory effect of cinchonine on human platelet aggregation due to blockade of calcium influxBiochemical Pharmacology, 1998
- The role of histamine in platelet aggregation by physiological and immunological stimuli.Inflammation Research, 1998
- ANTI-THROMBOTIC AND ANTI-INFLAMMATORY ACTIVITIES OF PROTOPINEPharmacological Research, 1997
- The H1-histamine receptor antagonist dithiaden inhibits stimulated platelet aggregation, malondialdehyde formation and thromboxane productionin vitroInflammation Research, 1995
- The Platelet-Stimulating Effect of Adrenaline Through α2-Adrenergic Receptors Requires Simultaneous Activation by a True Stimulatory Platelet AgonistThrombosis and Haemostasis, 1993
- A role for intracellular histamine in collagen-induced platelet aggregationBlood, 1990
- Histamine is an Intracellular Messenger Mediating Platelet AggregationScience, 1989
- Molecular mechanisms of platelet activation.Physiological Reviews, 1989
- Synergism of platelet-aggregating agents. Role of elevation of cytoplasmic calcium.Journal of Clinical Investigation, 1987